{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T21:23:18Z","timestamp":1777929798683,"version":"3.51.4"},"reference-count":0,"publisher":"S. Karger AG","license":[{"start":{"date-parts":[[2009,4,21]],"date-time":"2009-04-21T00:00:00Z","timestamp":1240272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/karger.com\/pages\/terms-and-conditions"},{"start":{"date-parts":[[2009,4,21]],"date-time":"2009-04-21T00:00:00Z","timestamp":1240272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/karger.com\/pages\/terms-and-conditions"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Onkologie"],"abstract":"<jats:p>Arzneimittelallergische Reaktionen sind von verschiedenen Zytosta-tika bekannt. Das Auftreten einer Urtikaria unter der Gabe von Cyclophosphamid ist bisher in nur 5 Fallen berichtet worden. In der vorliegenden Kasuistik wird \u00fcber eine 25j\u00e4hrige Patientin mit einem Morbus Hodgkin berichtet, die im Zusammenhang mit einer Cyclo-phosphamid-Infusion das Vollbild eines anaphylaktischen Schocks entwickelte. Die IgE-Konzentration im Blut war eine Woche nach dem Vorfall mit 1280 U\/ml stark erh\u00f6ht. Ein zu diesem Zeitpunkt durchgef\u00fchrter Epikutantest ergab eine stark positive, papulovesiku-l\u00f6se Hautreaktion gegen Cyclophosphamid-L\u00f6sung sowie gegen Cyclophosphamid-Trockensubstanz.<\/jats:p>","DOI":"10.1159\/000215206","type":"journal-article","created":{"date-parts":[[2009,4,22]],"date-time":"2009-04-22T10:40:22Z","timestamp":1240396822000},"page":"82-83","source":"Crossref","is-referenced-by-count":1,"title":["Anaphylaktische Reaktion unter Cyclophosphamid-Infusion"],"prefix":"10.1159","author":[{"given":"E.","family":"Aulbert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.G.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"127","published-online":{"date-parts":[[2009,4,21]]},"container-title":["Onkologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/215206","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/karger.com\/article-pdf\/doi\/10.1159\/000215206","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T23:54:04Z","timestamp":1777679644000},"score":1,"resource":{"primary":{"URL":"https:\/\/karger.com\/article\/doi\/10.1159\/000215206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,21]]},"references-count":0,"URL":"https:\/\/doi.org\/10.1159\/000215206","archive":["Portico"],"relation":{},"ISSN":["0378-584X","1423-0240"],"issn-type":[{"value":"0378-584X","type":"print"},{"value":"1423-0240","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,21]]}}}